The Cooper Companies, Inc. Common Stock (COO)

Price$69.46

Favorite Metrics

Price vs S&P 500 (26W)-6.28%

Price vs S&P 500 (4W)-9.35%

Market Capitalization$13.67B

P/E Ratio (Annual)36.47x

Indicated Dividend Yield (Annual)0.02%

All Metrics

P/CF (Annual)17.17x

Book Value / Share (Quarterly)$42.87

P/TBV (Annual)2.09x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)7.35%

Cash Flow / Share (Quarterly)$2.52

Payout Ratio (TTM)1.63%

Price vs S&P 500 (YTD)-18.66%

Gross Margin (TTM)65.44%

Net Profit Margin (TTM)9.67%

EPS (TTM)$2.02

10-Day Avg Trading Volume1.96M

EPS Excl Extra (TTM)$2.02

Revenue Growth (5Y)10.98%

EPS (Annual)$1.87

Dividend / Share (Annual)$0.00

ROI (Annual)3.49%

Gross Margin (Annual)65.54%

Net Profit Margin (5Y Avg)27.97%

Cash / Share (Quarterly)$0.64

P/E Basic Excl Extra (TTM)34.06x

Revenue Growth QoQ (YoY)6.16%

EPS Growth (5Y)9.30%

P/E Normalized (Annual)36.47x

ROA (Last FY)3.02%

Revenue Growth TTM (YoY)5.69%

EBITD / Share (TTM)$4.55

ROE (5Y Avg)12.22%

Operating Margin (TTM)17.19%

Cash Flow / Share (Annual)$2.21

P/B Ratio1.63x

P/B Ratio (Quarterly)1.89x

Net Income / Employee (Annual)$0

EV / Revenue (TTM)3.86x

Net Interest Coverage (TTM)6.25x

ROA (TTM)3.24%

EPS Growth QoQ (YoY)28.28%

EV / EBITDA (TTM)17.72x

EPS Incl Extra (Annual)$1.87

Current Ratio (Annual)1.89x

Quick Ratio (Quarterly)0.58x

3-Month Avg Trading Volume2.15M

52-Week Price Return-10.44%

EV / Free Cash Flow (Annual)37.00x

P/E Incl Extra (TTM)34.06x

Revenue / Employee (TTM)$0

Tangible BV / Share (Quarterly)$34.97

P/S Ratio (Annual)3.34x

Asset Turnover (Annual)0.33x

52-Week High$89.83

Operating Margin (5Y Avg)16.46%

EPS Excl Extra (Annual)$1.87

CapEx CAGR (5Y)3.15%

Tangible BV CAGR (5Y)21.28%

26-Week Price Return2.47%

Quick Ratio (Annual)0.84x

13-Week Price Return-14.24%

Total Debt / Equity (Annual)0.30x

Current Ratio (Quarterly)1.34x

Enterprise Value$16,046.465

Revenue / Share Growth (5Y)10.80%

Asset Turnover (TTM)0.33x

Book Value / Share Growth (5Y)53.92%

Revenue / Employee (Annual)$0

Inventory Turnover (Annual)1.71x

Pretax Margin (Annual)13.84%

Cash / Share (Annual)$0.56

3-Month Return Std Dev23.37%

Gross Margin (5Y Avg)66.04%

Net Income / Employee (TTM)$0

EBITDA CAGR (5Y)14.62%

EBITDA Interim CAGR (5Y)9.31%

ROE (Last FY)4.55%

Net Interest Coverage (Annual)6.89x

EPS Basic Excl Extra (Annual)$1.87

P/FCF (TTM)27.83x

Receivables Turnover (TTM)5.45x

EV / Free Cash Flow (TTM)32.67x

Total Debt / Equity (Quarterly)0.30x

EPS Incl Extra (TTM)$2.02

Receivables Turnover (Annual)5.29x

ROI (TTM)3.71%

P/S Ratio (TTM)3.29x

Pretax Margin (5Y Avg)14.29%

Revenue / Share (Annual)$20.46

Tangible BV / Share (Annual)$33.96

Forward P/E15.05x

Free OCF CAGR (5Y)19.74%

Price vs S&P 500 (52W)-45.54%

P/E Ratio (TTM)34.06x

EPS Growth TTM (YoY)-2.36%

Year-to-Date Return-14.52%

5-Day Price Return-2.29%

EPS Normalized (Annual)$1.87

ROA (5Y Avg)8.55%

Net Profit Margin (Annual)9.16%

Month-to-Date Return-2.01%

Cash Flow / Share (TTM)$12.84

EBITD / Share (Annual)$4.37

EPS Growth (3Y)-1.15%

Operating Margin (Annual)16.69%

LT Debt / Equity (Annual)0.30x

P/CF (TTM)15.78x

ROI (5Y Avg)9.79%

P/E Excl Extra (TTM)34.06x

LT Debt / Equity (Quarterly)0.22x

EPS Basic Excl Extra (TTM)$2.02

P/TBV (Quarterly)2.32x

Payout Ratio (Annual)0.78%

P/B Ratio (Annual)1.69x

Dividend / Share (TTM)$0.00

Inventory Turnover (TTM)1.67x

Pretax Margin (TTM)14.58%

Book Value / Share (Annual)$42.06

Price vs S&P 500 (13W)-17.10%

Net Margin Growth (5Y)-1.36%

Dividend Yield (TTM)0.00%

Beta0.99x

P/FCF (Annual)31.52x

Revenue / Share (TTM)$21.11

ROE (TTM)4.83%

52-Week Low$61.78

Analyst Recommendations

Jan 2026

Feb 2026

Mar 2026

Apr 2026

3.78

3.80

3.76

Industry Peers — Ophthalmic Goods(5)

Symbol	P/E Ratio (Annual)	ROE (TTM)	Revenue Growth (5Y)	Indicated Dividend Yield (Annual)	Price
COOThe Cooper Companies, Inc. Common Stock	36.47x	4.83%	10.98%	0.02%	$69.46
BLCOBausch + Lomb Corporation	—	-5.61%	8.38%	—	$16.76
WRBYWarby Parker Inc.	1889.51x	0.45%	17.24%	—	$25.89
EYENational Vision Holdings, Inc. Common Stock	68.41x	3.47%	3.03%	—	$25.49
STAAStaar Surgical Co	—	-23.24%	7.93%	—	$25.53
RXSTRxSight, Inc. Common Stock	—	-14.05%	55.73%	—	$7.44

About

CooperCompanies operates two leading market segments: CooperVision, which controls approximately 25% of the U.S. contact lens market with brands including Proclear and Biofinity, and CooperSurgical, a reproductive healthcare company with 17% market share in U.S. IUDs and comprehensive IVF device coverage. The company benefits from strong positions in both recurring consumer products and specialized medical devices. CooperVision maintains one of the world's most extensive specialty lens portfolios, while CooperSurgical offers integrated fertility solutions across the IVF cycle.